ether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.
Terms in quotation marks are defined in the Takeover Code, which can also be found on the Takeover Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Takeover Panel whose contact details are:
Tel: +44 (0) 207 638 0129; Fax +44 (0) 207 236 7013; email: info@thetakeoverpanel.org.uk.
About Inverness
By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. Inverness' global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.
For more information about Inverness Medical Innovations, please visit our website at http://www.invernessmedical.com.
For additional information on Concateno, please visit www.concateno.com
'/>"/>SOURCE Inverness Medical Innovations Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
Inverness Medical Innovations Agrees to Acquire Panbio Ltd.2.
Inverness - Chemogen Establish Exclusive License for TB Antibodies3.
Inverness Medical Innovations Announces Proposed Public Offering of Common Stock4.
Inverness Medical Innovations Agrees to Acquire ParadigmHealth5.
Inverness Medical Innovations Acquires ParadigmHealth6.
Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 8, 20087.
Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 20088.
Correction to Press Release Dated January 31, 2008: Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 20089.
Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc10.
Inverness Medical Innovations Announces Fourth Quarter 2007 Results11.
Inverness Medical Innovations to Participate at Bank of America 2008 Smid Cap Conference on March 26, 2008